Symposium | Future directions with novel and established BCMA-DT in the MM treatment paradigm episode artwork

EPISODE · Feb 11, 2026 · 9 MIN

Symposium | Future directions with novel and established BCMA-DT in the MM treatment paradigm

from Multiple Myeloma Hub

On December 17, 2025, the Multiple Myeloma Hub held a virtual symposium, titled Integrating novel BCMA-directed therapies into clinical practice: Insights from real-world experience. During the symposium, Maria Victoria Mateos provided an overview of the potential future directions with novel and established B-cell maturation antigen (BCMA)-directed therapies in the multiple myeloma (MM) treatment paradigm. This independent educational activity was supported by GSK. All content was developed independently by SES in collaboration with the faculty. The funder was allowed no influence on the content of this activity. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Feb 11, 2026

Embed this episode

NOW PLAYING

Symposium | Future directions with novel and established BCMA-DT in the MM treatment paradigm

0:00 9:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Multiple Myeloma Hub?

This episode is 9 minutes long.

When was this Multiple Myeloma Hub episode published?

This episode was published on February 11, 2026.

Can I download this Multiple Myeloma Hub episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!